Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESET CeD: Nexvax2 in Celiac Disease
NCT03644069Phase 2Unknown
- Sponsor
- ImmusanT
- Start
- Aug 2018
- Primary completion
- Sep 2019
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of nexvax2 in celiac disease, sponsored by ImmusanT. Status: unknown.
02
Drugs
nexvax2
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT03644069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03644069.